SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Turn Therapeutics announced publication of a peer-reviewed study in the Journal of Dermatological Treatment demonstrating GX-03's efficacy in an IL-36-associated inflammatory derma…
Precision BioSciences announced late-breaking clinical data from the ELIMINATE-B study demonstrating that PBGENE-HBV directly eliminated cccDNA with a 10-fold reduction in viral tr…
Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favorable safety profile. A Phase …
Apogee announced positive 16-week Part B induction dose optimization results from its Phase 2 APEX trial of zumilokibart, with 65.9% of mid-dose patients achieving EASI-75 endpoint…
Lumen Technologies filed amended and restated articles of incorporation detailing authorized capital structure of 2.2 billion common shares and 2 million preferred shares. The fili…
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. This auditor acknowledgment lette…
Solo Brands adopted an amended and restated 2021 incentive award plan to enhance recruitment and retention through expanded equity ownership opportunities for service providers. Th…
Five9 filed a restated certificate of incorporation dated May 20, 2026. This is a routine corporate governance filing with no material operational impact.
The Federal Reserve Board convened discount rate meetings on April 20 and April 29, 2026. The minutes document discussions and decisions from these monetary policy sessions.
Evolution Metals & Technologies Corp. regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Q1 2026 Form 10-Q on May 22, 2026, following a late filing notice on …
Precision BioSciences adopted a certificate amendment expanding protections for directors and officers from personal liability for breaches of fiduciary duty, subject to Delaware l…
Nasdaq initiated a delisting process against Vestand Inc. for non-compliance with filing requirements, specifically for failing to submit Forms 10-Q and 10-K. The company has reque…
Transocean Ltd. filed updated Articles of Association dated May 22, 2026, outlining the company's corporate structure and governance. The filing is primarily administrative and ref…
Omnicell, Inc. filed an amended and restated certificate of incorporation effective May 19, 2026, approved by its board and shareholders. The filing updates the company's Delaware …
ServisFirst Bancshares released an 8-K filing containing forward-looking statements and risk disclosures for a May 2026 presentation. The company cautions investors that actual res…
20/20 Biolabs' board approved Amendment No. 1 to its bylaws, effective May 19, 2026, reducing the quorum requirement for stockholder meetings from an unspecified prior level to one…
MaloneBailey, LLP acknowledged statements in AudioEye's Form 8-K filing dated May 26, 2026, relating to Item 4.01 disclosures. This typically signals an auditor change or accountin…
Veradigm completed filing of its comprehensive Form 10-K for 2023 and 2024, achieving a major compliance milestone after falling behind on SEC obligations. The company reported 202…
Insulet Corporation announced a voluntary medical device correction for approximately 7 million Omnipod pods across multiple product lines due to a manufacturing defect causing pot…
Dropbox, Inc. filed amended and restated articles of incorporation establishing a three-tier common stock structure with Class A, B, and C shares featuring different voting rights.…